CSF3R and myeloid neoplasm: In the current study, we performed mutational analysis using targeted next-generation sequencing (NGS) in a consecutive cohort of 360 patients diagnosed with myeloid neoplasms, to identify mutations in CSF3R gene in different subgroups.